Bacterial Alginate Regulators and Phage Homologs Repress CRISPR-Cas Immunity
Overview
Parasitology
Authors
Affiliations
CRISPR-Cas systems are adaptive immune systems that protect bacteria from bacteriophage (phage) infection. To provide immunity, RNA-guided protein surveillance complexes recognize foreign nucleic acids, triggering their destruction by Cas nucleases. While the essential requirements for immune activity are well understood, the physiological cues that regulate CRISPR-Cas expression are not. Here, a forward genetic screen identifies a two-component system (KinB-AlgB), previously characterized in the regulation of Pseudomonas aeruginosa alginate biosynthesis, as a regulator of the expression and activity of the P. aeruginosa Type I-F CRISPR-Cas system. Downstream of KinB-AlgB, activators of alginate production AlgU (a σ orthologue) and AlgR repress CRISPR-Cas activity during planktonic and surface-associated growth. AmrZ, another alginate regulator, is triggered to repress CRISPR-Cas immunity upon surface association. Pseudomonas phages and plasmids have taken advantage of this regulatory scheme and carry hijacked homologs of AmrZ that repress CRISPR-Cas expression and activity. This suggests that while CRISPR-Cas regulation may be important to limit self-toxicity, endogenous repressive pathways represent a vulnerability for parasite manipulation.
Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.
Ma J, Lu Z Microorganisms. 2025; 13(1).
PMID: 39858940 PMC: 11767912. DOI: 10.3390/microorganisms13010172.
Insight into the natural regulatory mechanisms and clinical applications of the CRISPR-Cas system.
Cheng H, Deng H, Ma D, Gao M, Zhou Z, Li H Heliyon. 2024; 10(20):e39538.
PMID: 39502233 PMC: 11535992. DOI: 10.1016/j.heliyon.2024.e39538.
AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmid.
Chen D, Roe L, Li Y, Borges A, Zhang J, Babbar P bioRxiv. 2024; .
PMID: 39253479 PMC: 11383003. DOI: 10.1101/2024.08.26.609590.
Correlation of Phage Resistance with the Numbers and Types of Antiphage Systems.
Burke K, Urick C, Mzhavia N, Nikolich M, Filippov A Int J Mol Sci. 2024; 25(3).
PMID: 38338703 PMC: 10855318. DOI: 10.3390/ijms25031424.
Inhibitors of bacterial immune systems: discovery, mechanisms and applications.
Mayo-Munoz D, Pinilla-Redondo R, Camara-Wilpert S, Birkholz N, Fineran P Nat Rev Genet. 2024; 25(4):237-254.
PMID: 38291236 DOI: 10.1038/s41576-023-00676-9.